150 related articles for article (PubMed ID: 20570892)
21. Cellular cholesterol regulates MT1 MMP dependent activation of MMP 2 via MEK-1 in HT1080 fibrosarcoma cells.
Atkinson SJ; English JL; Holway N; Murphy G
FEBS Lett; 2004 May; 566(1-3):65-70. PubMed ID: 15147870
[TBL] [Abstract][Full Text] [Related]
22. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
Hong SK; Wu PK; Karkhanis M; Park JI
Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a novel mitogen-activated protein kinase kinase 1/2 inhibitor with a unique mechanism of action for cancer therapy.
Daouti S; Wang H; Li WH; Higgins B; Kolinsky K; Packman K; Specian A; Kong N; Huby N; Wen Y; Xiang Q; Podlaski FJ; He Y; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2009 Mar; 69(5):1924-32. PubMed ID: 19244124
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
[TBL] [Abstract][Full Text] [Related]
25. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
Front Immunol; 2018; 9():364. PubMed ID: 29535732
[TBL] [Abstract][Full Text] [Related]
26. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.
Ueyama T; Kawashima S; Sakoda T; Rikitake Y; Ishida T; Kawai M; Yamashita T; Ishido S; Hotta H; Yokoyama M
J Mol Cell Cardiol; 2000 Jun; 32(6):947-60. PubMed ID: 10888249
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
28. A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.
Catalanotti F; Reyes G; Jesenberger V; Galabova-Kovacs G; de Matos Simoes R; Carugo O; Baccarini M
Nat Struct Mol Biol; 2009 Mar; 16(3):294-303. PubMed ID: 19219045
[TBL] [Abstract][Full Text] [Related]
29. Small GTPase RBJ mediates nuclear entrapment of MEK1/MEK2 in tumor progression.
Chen T; Yang M; Yu Z; Tang S; Wang C; Zhu X; Guo J; Li N; Zhang W; Hou J; Liu H; Han C; Liu Q; Gu Y; Qian C; Wan T; Cui L; Zhu M; Zheng W; Cao X
Cancer Cell; 2014 May; 25(5):682-96. PubMed ID: 24746703
[TBL] [Abstract][Full Text] [Related]
30. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
[TBL] [Abstract][Full Text] [Related]
31. Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.
Grewal S; Molina DM; Bardwell L
Cell Signal; 2006 Jan; 18(1):123-34. PubMed ID: 15979847
[TBL] [Abstract][Full Text] [Related]
32. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.
Zhang HY; Zhang X; Chen X; Thomas D; Hormi-Carver K; Elder F; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G470-8. PubMed ID: 18617556
[TBL] [Abstract][Full Text] [Related]
33. Distinct genetic alterations in the mitogen-activated protein kinase pathway dictate sensitivity of thyroid cancer cells to mitogen-activated protein kinase kinase 1/2 inhibition.
Schweppe RE; Kerege AA; Sharma V; Poczobutt JM; Gutierrez-Hartmann A; Grzywa RL; Haugen BR
Thyroid; 2009 Aug; 19(8):825-35. PubMed ID: 19500021
[TBL] [Abstract][Full Text] [Related]
34. Mitogen-activated protein kinase dynamics during the meiotic G2/MI transition of mouse spermatocytes.
Inselman A; Handel MA
Biol Reprod; 2004 Aug; 71(2):570-8. PubMed ID: 15084480
[TBL] [Abstract][Full Text] [Related]
35. Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2004 Mar; 378(Pt 2):569-77. PubMed ID: 14616089
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
37. Beyond focal adhesions: integrin-linked kinase associates with tubulin and regulates mitotic spindle organization.
Fielding AB; Dobreva I; Dedhar S
Cell Cycle; 2008 Jul; 7(13):1899-906. PubMed ID: 18604167
[TBL] [Abstract][Full Text] [Related]
38. Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells.
Gao SY; Li EM; Cui L; Lu XF; Meng LY; Yuan HM; Xie JJ; Du ZP; Pang JX; Xu LY
J Biol Chem; 2009 Mar; 284(12):7995-8004. PubMed ID: 19164283
[TBL] [Abstract][Full Text] [Related]
39. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
40. Salinomycin causes migration and invasion of human fibrosarcoma cells by inducing MMP-2 expression via PI3-kinase, ERK-1/2 and p38 kinase pathways.
Yu SM; Kim SJ
Int J Oncol; 2016 Jun; 48(6):2686-92. PubMed ID: 27035160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]